Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture
N. Yamada(National Institute of Infectious Diseases), Takanobu Kato(National Institute of Infectious Diseases), Kohji Moriishi(Hokkaido University), Senko Tsukuda(National Institute of Infectious Diseases), Hussein Hassan Aly(National Institute of Infectious Diseases), Kazumoto Murata(National Center for Global Health and Medicine), Masamichi Muramatsu(National Institute of Infectious Diseases), Hironori Nishitsuji(Fujita Health University), Masaya Sugiyama(National Center for Global Health and Medicine), Masashi Iwamoto(Rockefeller University), Koichi Watashi(Tokyo University of Science), Tomohisa Tanaka(Hokkaido University), Kunitada Shimotohno(National Center for Global Health and Medicine), Asako Murayama(National Institute of Infectious Diseases), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Masaaki Shiina(Yokohama City University)
Cited by 9
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k